Netherlands vs New Zealand: Number of isolates tested for ceftriaxone
Netherlands
332
in 2020
New Zealand
861
in 2020
Netherlands rank
9th
New Zealand rank
7th
Number of isolates tested for ceftriaxone over time
- Netherlands
- New Zealand
How they compare
New Zealand currently reports 861 against 332 in Netherlands, a difference of 529.
That makes New Zealand's figure about 2.6 times Netherlands's.
Across all 9 years both countries report, New Zealand has been ahead every year.
Netherlands ranks 9th and New Zealand ranks 7th of 52 countries.
New Zealand has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Netherlands | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 114 | 234 | 120 | New Zealand |
| 2010s | 216.29 | 383.14 | 166.86 | New Zealand |
| 2020s | 332 | 861 | 529 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Netherlands or New Zealand?
- New Zealand, at 861 against 332 in Netherlands as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between Netherlands and New Zealand?
- 529, with New Zealand ahead.
- How many years of comparable data are there for Netherlands and New Zealand?
- 9 years are reported by both, from 2009 to 2020.
- How do Netherlands and New Zealand rank globally for number of isolates tested for ceftriaxone?
- Netherlands ranks 9th and New Zealand ranks 7th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.